While Trulieve records slight growth, MSOs like Verano and Cresco Labs face price compression and revenue contraction

While Germany increases its quota to meet record demand, Australia reduces its ceiling for medicinal cannabis imports due to unused licenses

With the drug Ver-01, the entrepreneur aims to offer a safe and effective alternative for the treatment of chronic pain, targeting a $20 billion market dominated by opioids

Discover what scientific evidence says, the real risks of excessive consumption, and how to use cannabis responsibly

The Trump administration is considering reclassifying marijuana as a lower-risk drug, a move that would facilitate research, investments, and tax deductions for the sector

Understand everything about cannabidiol

Patients whose data was exposed by the agency fear being targeted for advertising and retaliation

Coalition accuses retailers of selling marijuana as hemp and operating outside the regulated market

New research relies on rigorous methodologies, such as double-blind studies, and investigates the potential of lesser-known cannabinoids, such as CBG and THCV

A scientific review highlights the lack of robust evidence on medical cannabis and reinforces the need for more rigorous and balanced research in the field

Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

The Italian Constitutional Court is assessing the legality of the ban on industrial hemp flowers, while judicial decisions, European pressures, and proposals for state monopoly reshape the sector's future in the country

Presented at the Brazilian Medicinal Cannabis Congress 2025, the CBD foam facilitates hygiene and treatment of chronic wounds and burns

The research, conducted by the Neuroscience Laboratory at UNILA, aims to advance the treatment of mental disorders through new scientific approaches

Regulatory agency's approval includes adjustments in testing of products with shelf lives between 18 and 24 months manufactured by Prati-Donaduzzi and Promediol

Research indicates that psilocybin may offer serenity to end-of-life patients, uniting science, empathy, and a new perspective on dying.

From cultivation to sale, innovations in automation, data analysis, and post-harvest are shaping the future of the global market, ensuring quality, efficiency, and compliance

The former president's post about the benefits of hemp-derived CBD for seniors moved the cannabis market in the U.S.

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Clinical research suggests improvement in pain perception and emotional symptoms